Sectoral Asset Management
Latest statistics and disclosures from Sectoral Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LENZ, CTNM, LLY, UNH, GILD, and represent 41.23% of Sectoral Asset Management's stock portfolio.
- Added to shares of these 10 stocks: AMGN, LLY, HCAT, PRVA, CLOV, UNH, GPCR, BNTX, MLYS, CI.
- Started 9 new stock positions in CLOV, IOVA, PRVA, IOBT, AXSM, CI, CRGX, HCAT, INCY.
- Reduced shares in these 10 stocks: IQV, ZBH, QURE, EW, , OPCH, EVH, PFE, GILD, GDRX.
- Sold out of its positions in APLS, DXCM, EVH, GDRX, IQV, CATX, ITOS, JPST, KYTX, OPCH. ZBH, ICLR, ADCT.
- Sectoral Asset Management was a net seller of stock by $-12M.
- Sectoral Asset Management has $150M in assets under management (AUM), dropping by -11.50%.
- Central Index Key (CIK): 0001274413
Tip: Access up to 7 years of quarterly data
Positions held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 86 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Lenz Therapeutics (LENZ) | 18.8 | $28M | 977k | 28.87 |
|
|
| Contineum Therapeuti Cl A (CTNM) | 7.8 | $12M | 801k | 14.65 |
|
|
| Eli Lilly & Co. (LLY) | 6.5 | $9.7M | +14% | 13k | 772.00 |
|
| UnitedHealth (UNH) | 4.9 | $7.4M | +11% | 15k | 505.86 |
|
| Gilead Sciences (GILD) | 3.2 | $4.7M | -15% | 51k | 92.37 |
|
| Mineralys Therapeutics (MLYS) | 3.1 | $4.7M | +15% | 381k | 12.31 |
|
| Abbvie (ABBV) | 2.2 | $3.3M | +18% | 19k | 177.70 |
|
| Johnson & Johnson (JNJ) | 2.2 | $3.3M | -11% | 23k | 144.62 |
|
| Amgen (AMGN) | 2.2 | $3.3M | +77% | 13k | 260.64 |
|
| Boston Scientific Corporation (BSX) | 1.9 | $2.9M | 33k | 89.32 |
|
|
| Abbott Laboratories (ABT) | 1.8 | $2.8M | +25% | 24k | 113.11 |
|
| Bristol Myers Squibb (BMY) | 1.7 | $2.5M | -12% | 44k | 56.56 |
|
| Thermo Fisher Scientific (TMO) | 1.7 | $2.5M | -9% | 4.8k | 520.50 |
|
| Merck & Co (MRK) | 1.6 | $2.4M | +2% | 25k | 99.48 |
|
| Regeneron Pharmaceuticals (REGN) | 1.6 | $2.4M | 3.4k | 712.33 |
|
|
| Stryker Corporation (SYK) | 1.5 | $2.3M | -14% | 6.4k | 360.64 |
|
| Biontech Se Spn Ads (BNTX) | 1.4 | $2.2M | +44% | 19k | 113.95 |
|
| Medtronic SHS (MDT) | 1.4 | $2.1M | -10% | 26k | 80.37 |
|
| Argenx Se Spn Adr (ARGX) | 1.4 | $2.1M | -14% | 3.4k | 615.00 |
|
| Pfizer (PFE) | 1.4 | $2.1M | -32% | 78k | 26.53 |
|
| Boundless Bio (BOLD) | 1.3 | $2.0M | 679k | 2.90 |
|
|
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $2.0M | -14% | 8.3k | 235.31 |
|
| BioMarin Pharmaceutical (BMRN) | 1.3 | $1.9M | -20% | 29k | 65.73 |
|
| Danaher Corporation (DHR) | 1.1 | $1.7M | +52% | 7.3k | 229.74 |
|
| Neurocrine Biosciences (NBIX) | 1.1 | $1.6M | -5% | 12k | 136.50 |
|
| Intuitive Surgic Com New (ISRG) | 1.1 | $1.6M | 3.1k | 521.96 |
|
|
| Vaxcyte (PCVX) | 1.0 | $1.6M | +30% | 19k | 81.86 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.0 | $1.5M | -24% | 3.7k | 402.70 |
|
| Sarepta Therapeutics (SRPT) | 0.9 | $1.3M | -10% | 11k | 121.59 |
|
| Structure Therapeu Spn Ads (GPCR) | 0.9 | $1.3M | +101% | 49k | 27.12 |
|
| Moonlake Immunothera Class A Ord (MLTX) | 0.9 | $1.3M | -13% | 24k | 54.15 |
|
| Amicus Therapeutics (FOLD) | 0.9 | $1.3M | -4% | 136k | 9.42 |
|
| Uniqure SHS (QURE) | 0.8 | $1.3M | -53% | 72k | 17.66 |
|
| Zai Lab Adr (ZLAB) | 0.8 | $1.2M | -38% | 45k | 26.19 |
|
| Cytokinetics Com New (CYTK) | 0.8 | $1.2M | -14% | 25k | 47.04 |
|
| Health Catalyst (HCAT) | 0.8 | $1.1M | NEW | 160k | 7.07 |
|
| Tarsus Pharmaceuticals (TARS) | 0.8 | $1.1M | +79% | 20k | 55.37 |
|
| Silverback Therapeutics (SPRY) | 0.7 | $1.1M | +7% | 106k | 10.55 |
|
| Blueprint Medicines (BPMC) | 0.7 | $1.1M | -15% | 13k | 87.22 |
|
| Arcus Biosciences Incorporated (RCUS) | 0.7 | $1.0M | -7% | 70k | 14.89 |
|
| Privia Health Group (PRVA) | 0.7 | $1.0M | NEW | 52k | 19.55 |
|
| CVS Caremark Corporation (CVS) | 0.7 | $988k | -13% | 22k | 44.89 |
|
| Legend Biotech Corp Spn Ads (LEGN) | 0.6 | $970k | +9% | 30k | 32.54 |
|
| Astrazeneca Spn Adr (AZN) | 0.6 | $960k | -31% | 15k | 65.52 |
|
| Clover Health Inv Com Cl A (CLOV) | 0.6 | $866k | NEW | 275k | 3.15 |
|
| Ishares Tr 0-3 Mnth Treasry (SGOV) | 0.5 | $803k | -47% | 8.0k | 100.33 |
|
| Inari Medical Ord (NARI) | 0.5 | $774k | -39% | 15k | 51.05 |
|
| Cigna Corp (CI) | 0.4 | $621k | NEW | 2.3k | 276.14 |
|
| Iovance Biotherapeutics (IOVA) | 0.4 | $603k | NEW | 82k | 7.40 |
|
| Biogen Idec (BIIB) | 0.4 | $589k | -36% | 3.9k | 152.92 |
|
| Illumina (ILMN) | 0.4 | $584k | -23% | 4.4k | 133.63 |
|
| Edwards Lifesciences (EW) | 0.4 | $581k | -69% | 7.9k | 74.03 |
|
| Arvinas Ord (ARVN) | 0.4 | $578k | -34% | 30k | 19.17 |
|
| Cogent Biosciences (COGT) | 0.4 | $576k | -12% | 74k | 7.80 |
|
| Summit Therapeutics (SMMT) | 0.4 | $535k | +12% | 30k | 17.84 |
|
| Engene Holdings (ENGN) | 0.4 | $525k | -16% | 79k | 6.65 |
|
| Insmed (INSM) | 0.3 | $509k | -23% | 7.4k | 69.04 |
|
| Rocket Pharmaceuticals (RCKT) | 0.3 | $505k | -7% | 40k | 12.57 |
|
| Intra Cellular Therapies (ITCI) | 0.3 | $409k | -23% | 4.9k | 83.52 |
|
| Roivant Sciences SHS (ROIV) | 0.3 | $408k | -23% | 35k | 11.83 |
|
| Humana (HUM) | 0.3 | $401k | -27% | 1.6k | 253.71 |
|
| Beigene Spn Adr | 0.2 | $371k | -23% | 2.0k | 184.71 |
|
| Olema Pharmaceuticals (OLMA) | 0.2 | $359k | -6% | 62k | 5.83 |
|
| Bridgebio Pharma (BBIO) | 0.2 | $316k | -23% | 12k | 27.44 |
|
| Medpace Hldgs (MEDP) | 0.2 | $276k | -23% | 830.00 | 332.23 |
|
| Ptc Therapeutics I (PTCT) | 0.2 | $262k | -23% | 5.8k | 45.14 |
|
| Turnstone Biologics Corp (TSBX) | 0.2 | $257k | 518k | 0.50 |
|
|
| Ionis Pharmaceuticals (IONS) | 0.2 | $252k | -23% | 7.2k | 34.96 |
|
| Vera Therapeutics Cl A (VERA) | 0.2 | $241k | -23% | 5.7k | 42.29 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.2 | $225k | -24% | 4.4k | 51.13 |
|
| Geron Corporation (GERN) | 0.2 | $225k | +38% | 64k | 3.54 |
|
| Ascendis Pharma As Spn Adr (ASND) | 0.1 | $220k | -25% | 1.6k | 137.67 |
|
| Jazz Pharma Shs Usd (JAZZ) | 0.1 | $216k | -23% | 1.8k | 123.15 |
|
| Revolution Medicines (RVMD) | 0.1 | $214k | -23% | 4.9k | 43.74 |
|
| United Therapeutics Corporation (UTHR) | 0.1 | $210k | -43% | 595.00 | 352.84 |
|
| Springworks Therapeutics (SWTX) | 0.1 | $199k | -45% | 5.5k | 36.13 |
|
| Viatris (VTRS) | 0.1 | $194k | -39% | 16k | 12.45 |
|
| Novo-nordisk As Adr (NVO) | 0.1 | $189k | 2.2k | 86.02 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 0.1 | $184k | -56% | 7.2k | 25.51 |
|
| Moderna (MRNA) | 0.1 | $181k | -68% | 4.4k | 41.58 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $176k | -45% | 570.00 | 308.57 |
|
| Incyte Corporation (INCY) | 0.1 | $173k | NEW | 2.5k | 69.07 |
|
| Cargo Therapeutics (CRGX) | 0.1 | $123k | NEW | 8.5k | 14.42 |
|
| Exelixis (EXEL) | 0.1 | $117k | -68% | 3.5k | 33.30 |
|
| Axsome Therapeutics (AXSM) | 0.0 | $69k | NEW | 820.00 | 84.61 |
|
| Io Biotech (IOBT) | 0.0 | $69k | NEW | 75k | 0.92 |
|
Past Filings by Sectoral Asset Management
SEC 13F filings are viewable for Sectoral Asset Management going back to 2010
- Sectoral Asset Management 2024 Q4 filed Feb. 14, 2025
- Sectoral Asset Management 2024 Q3 filed Nov. 14, 2024
- Sectoral Asset Management 2024 Q2 filed Aug. 13, 2024
- Sectoral Asset Management 2024 Q1 filed May 14, 2024
- Sectoral Asset Management 2023 Q4 filed Feb. 14, 2024
- Sectoral Asset Management 2023 Q3 filed Nov. 14, 2023
- Sectoral Asset Management 2023 Q2 filed Aug. 11, 2023
- Sectoral Asset Management 2023 Q1 filed May 12, 2023
- Sectoral Asset Management 2022 Q4 filed Feb. 10, 2023
- Sectoral Asset Management 2022 Q3 filed Nov. 10, 2022
- Sectoral Asset Management 2022 Q2 filed Aug. 15, 2022
- Sectoral Asset Management 2022 Q1 filed May 10, 2022
- Sectoral Asset Management 2021 Q4 filed Feb. 11, 2022
- Sectoral Asset Management 2021 Q3 filed Nov. 15, 2021
- Sectoral Asset Management 2021 Q2 filed Aug. 16, 2021
- Sectoral Asset Management 2021 Q1 filed May 14, 2021